Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The adrenergic pathway and heart failure.

J R Keys1, W J Koch

  • 1Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

Recent Progress in Hormone Research
|January 30, 2004
PubMed
Summary

Genetically engineered mouse models reveal that inhibiting GRK2 (beta adrenergic receptor kinase 1) may improve heart failure. These models offer insights into adrenergic signaling in cardiac dysfunction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model.

Gene therapy·2013
Same author

Myocardial β(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure.

British journal of pharmacology·2012
Same author

Targeting GRK2 by gene therapy for heart failure: benefits above β-blockade.

Gene therapy·2012
Same author

Gene therapy targets in heart failure: the path to translation.

Clinical pharmacology and therapeutics·2011
Same author

Gene transfer strategies for augmenting cardiac function.

Trends in cardiovascular medicine·2011
Same author

Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo.

Gene therapy·2011

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Pharmacology

Background:

  • Heart failure shares common molecular features despite diverse causes.
  • Heightened sympathetic nervous system activation and adrenergic signaling are key in heart failure.

Purpose of the Study:

  • To review transgenic and knockout mouse models for studying the adrenergic system in normal and failing hearts.
  • To highlight insights gained from these models regarding cardiac function and dysfunction.

Main Methods:

  • Utilized genetically engineered mouse models.
  • Studied alterations in adrenergic receptors, G proteins, and G protein-coupled receptor kinases (GRKs).

Main Results:

  • Inhibition of GRK2 (betaARK1) shows potential as a therapeutic strategy for heart failure.
  • Transgenic research suggests hypertension plays a role in heart failure development.

Conclusions:

  • Genetically engineered mouse models provide valuable insights into myocardial signaling in cardiac health and disease.
  • Targeting GRK2 represents a promising therapeutic avenue for heart failure.

Related Experiment Videos